Farallon Capital Management
http://www.faralloncapital.com/farallon/index.htmFarallon Capital Management is an investment firm than manages equity capital for institutions and high net worth individuals. The firm's institutional investors are primarily college endowments and foundations. Farallon primarily invests in businesses and securities that are undergoing change or will appreciate because of an expected event which includes mergers, restructurings, recapitalizations or other major changes. The firm seeks to build strong relationships with the management of companies in which it invests.
View Older Stories View More Recent Stories
-
Pre-Open Stock Movers 11/19: (FENT) (APVO) (SONO) Higher; (MGTX) (GPRO) (CUB) Lower (more...)
-
Imago BioSciences Raises $80 Million in Series C Financing
-
Playa Hotels & Resorts (PLYA) Prices 13.576M Share Upsized Secondary Offering at $4.10/Sh
-
Playa Hotels & Resorts N.V. Announces Pricing of Upsized Secondary Offering of 13,575,739 Ordinary Shares by Selling Shareholders
-
Playa Hotels & Resorts N.V. Announces Pricing of Upsized Secondary Offering of 13,575,739 Ordinary Shares by Selling Shareholders
-
Playa Hotels & Resorts (PLYA) Announces Secondary Offering of 12.5M Ordinary Shares by Selling Shareholders
-
Playa Hotels & Resorts N.V. Announces Secondary Offering of 12,500,000 Ordinary Shares by Selling Shareholders
-
Playa Hotels & Resorts N.V. Announces Secondary Offering of 12,500,000 Ordinary Shares by Selling Shareholders
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-NT Farallon Capital Europe For: Sep 30
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M Financing, Building a Novel Neuroscience Drug Development Company
-
Digimarc Welcomes Noted Venture Capitalist and Advisor Alicia Syrett to its Board of Directors
-
Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
-
Form SC 13G AMYRIS, INC. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-NT Farallon Capital Europe For: Jun 30
-
TOCA Football To Open The World's First Soccer Entertainment Venue In London
-
AUTO1 raises $300 million to develop used-car retail platform
-
Argentina: Letter of Support of Joint Debt Restructuring Proposal
-
U.S. hedge fund Farallon to vote for activist-backed Toshiba board nominees
-
Farallon plans to vote for the shareholder proposals at Toshiba's 181st Annual General Meeting
-
Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in SCN1A+ Dravet Syndrome and Advance Preclinical Pipeline of Gene Therapies for Debilitating Neurologic
-
Proxy advisers ISS, Glass Lewis back Toshiba, recommend against dissidents
-
BioAtla Raises $72.5 Million In Series D Financing
-
Effissimo tells Toshiba that shareholders make good directors
-
MEDNAX Announces Leadership and Board Transitions
-
Form D/A Farallon Capital F5 Inve
-
Form D/A Farallon Capital F5 Inve
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Atento Announces New Board of Directors
-
BGL Business Services Insider - Contact Center Outsourcing Continuing to Gain Market Share, with M&A Acting as a Growth Lever
-
Form 4 Generation Bio Co. For: Jun 16 Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-NT Farallon Capital Europe For: Mar 31
-
Private creditors push back against blanket debt relief for Africa
-
Private Creditors Establish the Africa Private Creditor Working Group (“AfricaPCWG” or the “Group”)
-
Atento Reports Fiscal 2020 First Quarter Results
-
Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
-
Atento S.A. (ATTO) Reports Institutional Investors to Acquire Bain Capital's Equity in Company
-
Atento Announces Institutional Investors to Acquire Bain Capital's Equity in the Company
-
Form D/A FARALLON CAPITAL OFFSHOR
-
Form D/A Farallon Capital Institu

